4.3 Review

The role of radiomics in prostate cancer radiotherapy

Journal

STRAHLENTHERAPIE UND ONKOLOGIE
Volume 196, Issue 10, Pages 900-912

Publisher

SPRINGER HEIDELBERG
DOI: 10.1007/s00066-020-01679-9

Keywords

Radiogenomics; Delta-radiomics; Multiparametric MRI; Cone beam CT

Ask authors/readers for more resources

Radiomics, as it refers to the extraction and analysis of a large number of advanced quantitative radiological features from medical images using high-throughput methods, is perfectly suited as an engine for effectively sifting through the multiple series of prostate images from before, during, and after radiotherapy (RT). Multiparametric (mp)MRI, planning CT, and cone beam CT (CBCT) routinely acquired throughout RT and the radiomics pipeline are developed for extraction of thousands of variables. Radiomics data are in a format that is appropriate for building descriptive and predictive models relating image features to diagnostic, prognostic, or predictive information. Prediction of Gleason score, the histopathologic cancer grade, has been the mainstay of the radiomic efforts in prostate cancer. While Gleason score (GS) is still the best predictor of treatment outcome, there are other novel applications of quantitative imaging that are tailored to RT. In this review, we summarize the radiomics efforts and discuss several promising concepts such as delta-radiomics and radiogenomics for utilizing image features for assessment of the aggressiveness of prostate cancer and its outcome. We also discuss opportunities for quantitative imaging with the advance of instrumentation in MRI-guided therapies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Radiology, Nuclear Medicine & Medical Imaging

Assessment of daily dose accumulation for robustly optimized intensity modulated proton therapy treatment of prostate cancer

Yihang Xu, Tejan Diwanji, Nellie Brovold, Michael Butkus, Kyle R. Padgett, Ryder M. Schmidt, Adam King, Alan Dal Pra, Matt Abramowitz, Alan Pollack, Nesrin Dogan

Summary: The study implemented a daily CBCT based dose accumulation technique to assess ideal robust optimization parameters for IMPT treatment of prostate cancer. Results indicated that plans with +/- 3mm/+/- 3% uncertainty provided satisfactory CTV coverage and superior sparing to OARs compared to plans with +/- 5 mm/+/- 3% uncertainty. Weekly dose accumulation accurately estimated the overall dose delivered to prostate cancer patients.

PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Repeatability of CBCT radiomic features and their correlation with CT radiomic features for prostate cancer

Rodrigo Delgadillo, Benjamin O. Spieler, John C. Ford, Deukwoo Kwon, Fei Yang, Matthew Studenski, Kyle R. Padgett, Matthew C. Abramowitz, Alan Dal Pra, Radka Stoyanova, Alan Pollack, Nesrin Dogan

Summary: This study investigated the quality of CBCT-based radiomic features and their relationship with reconstruction and preprocessing methods. It was found that CBCT radiomic features are generally more repeatable than reproducible, and certain features from specific classes showed high levels of repeatability and reproducibility. The study suggests that improving repeatability of CBCT radiomic features through reconstruction and preprocessing methods may decrease their reproducibility.

MEDICAL PHYSICS (2021)

Article Multidisciplinary Sciences

Assessment of CT to CBCT contour mapping for radiomic feature analysis in prostate cancer

Ryder M. Schmidt, Rodrigo Delgadillo, John C. Ford, Kyle R. Padgett, Matthew Studenski, Matthew C. Abramowitz, Benjamin Spieler, Yihang Xu, Fei Yang, Nesrin Dogan

Summary: This study quantitatively assessed the accuracy of a commercially available deformable image registration (DIR) algorithm in generating prostate contours, showing high consistency between auto-generated and manually drawn contours, as well as good robustness of radiomic features to differing contours. The majority of DIRs were within recommended tolerance, indicating promising potential for auto contour usage in radiomic feature analysis.

SCIENTIFIC REPORTS (2021)

Article Oncology

Levels of Evidence for Radiation Therapy Recommendations in the National Comprehensive Cancer Network (NCCN) Clinical Guidelines

Miguel Angel Noy, Benjamin J. Rich, Ricardo Llorente, Deukwoo Kwon, Matthew Abramowitz, Brandon Mahal, Eric A. Mellon, Nicholas G. Zaorsky, Alan Dal Pra

Summary: The study found that only 9.7% of radiation therapy recommendations in NCCN guidelines are category I evidence, with the highest levels of evidence for radiation therapy found in breast and cervical cancers. There is a significant difference in the distribution of consensus and evidence between radiation therapy recommendations and systemic therapy recommendations. The proportion of category I evidence is significantly higher in systemic therapy recommendations compared to radiation therapy recommendations.

ADVANCES IN RADIATION ONCOLOGY (2022)

Article Oncology

Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer

Benjamin J. Rich, Chris Montoya, William H. Jin, Benjamin O. Spieler, Brandon A. Mahal, Rodrigo Delgadillo, Marijo Bilusic, Matthew C. Abramowitz, Alan Pollack, Alan Dal Pra

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)

Article Multidisciplinary Sciences

Cone-beam CT delta-radiomics to predict genitourinary toxicities and international prostate symptom of prostate cancer patients: a pilot study

Rodrigo Delgadillo, Benjamin O. Spieler, Anthony M. Deana, John C. Ford, Deukwoo Kwon, Fei Yang, Matthew T. Studenski, Kyle R. Padgett, Matthew C. Abramowitz, Alan Dal Pra, Radka Stoyanova, Nesrin Dogan

Summary: This study investigated the performance of CBCT-based delta-radiomic features (DRF) models in predicting acute and sub-acute International Prostate Symptom Scores (IPSS) and Common Terminology Criteria for Adverse Events (CTCAE) version 5 GU toxicity grades for prostate cancer (PCa) patients treated with definitive radiotherapy (RT). The results showed that the DRF models based on CBCT images could accurately predict IPSS and CTCAE grades as early as week 1 of treatment. This study highlights the potential of using CBCT-based DRF models for predicting RT outcomes.

SCIENTIFIC REPORTS (2022)

Meeting Abstract Oncology

Cost-Effectiveness Threshold of Magnetic Resonance Image-Guided Radiotherapy for Localized Prostate Cancer

L. E. D. Schumacher, A. Dal Pra, S. Hoffe, E. A. Mellon

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)

Meeting Abstract Oncology

Checkpoint Inhibitor Pneumonitis in Patients with Advanced NSCLC on Nivolumab Monotherapy is Underreported and Associated with Prior Radiotherapy History

B. Spieler, G. Azzam, D. Kwon, D. Saravia, G. Lopes, A. Dal Pra, T. Diwanji, R. Yechieli, L. M. Freedman, I. B. Mihaylov

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)

Meeting Abstract Oncology

The Effects of Androgen-Deprivation Therapy on MRI Delta Radiomics Features in a Prospective Radiotherapy Treatment Trial for Prostate Cancer

R. Stoyanova, C. Lopez, A. L. Breto, I. R. Xu, D. Kwon, G. C. Franco, A. Dal Pra, M. C. Abramowitz, S. Punnen, A. Pollack

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)

Meeting Abstract Oncology

Genomic Heterogeneity in Prognostic Signatures from Prostate Biopsies: Results from Two Prospective Trials

R. Stoyanova, S. Punnen, D. Kwon, I. M. Reis, N. Soodana Prakash, S. M. Gaston, C. R. Rich, B. Nahar, M. L. Gonzalgo, B. Kava, R. P. Castillo Acosta, O. N. Kryvenko, A. Dal Pra, M. C. Abramowitz, E. Davicioni, D. J. Parekh, A. Pollack

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)

Meeting Abstract Oncology

Post-Treatment Biopsy Positivity In Prostate Cancer Patients Undergoing MpMRI-Targeted Radiation Dose Escalation

J. J. Meshman, B. Farnia, R. Stoyanova, A. Dal Pra, M. C. Abramowitz, I. M. Reis, D. Kwon, S. Punnen, E. M. Horwitz, A. Pollack

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)

Meeting Abstract Oncology

Temporal Changes of Circulating Tumor Cells in Prostate Cancer Patients after Radiation Therapy

T. M. Giret, R. Stoyanova, S. Ansari, T. Tulasigeri, M. Jorda, A. Dal Pra, M. C. Abramowitz, S. Punnen, A. Pollack

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)

Article Environmental Sciences

Apparent dust size discrepancy in aerosol reanalysis in north African dust after long-range transport

Samantha J. Kramer, Claudia Alvarez, Anne E. Barkley, Peter R. Colarco, Lillian Custals, Rodrigo Delgadillo, Cassandra J. Gaston, Ravi Govindaraju, Paquita Zuidema

ATMOSPHERIC CHEMISTRY AND PHYSICS (2020)

No Data Available